Literature DB >> 29712998

A novel role for CAMKIIβ in the regulation of cortical neuron migration: implications for neurodevelopmental disorders.

Olivier Nicole1,2, Donald M Bell3, Thierry Leste-Lasserre4, Hélène Doat4, François Guillemot5, Emilie Pacary6,7.   

Abstract

Perturbation of CaMKIIβ expression has been associated with multiple neuropsychiatric diseases, highlighting CaMKIIβ as a gene of interest. Yet, in contrast to CaMKIIα, the specific functions of CaMKIIβ in the brain remain poorly explored. Here, we reveal a novel function for this CaMKII isoform in vivo during neuronal development. By using in utero electroporation, we show that CaMKIIβ is an important regulator of radial migration of projection neurons during cerebral cortex development. Knockdown of CaMKIIβ causes accelerated migration of nascent pyramidal neurons, whereas overexpression of CaMKIIβ inhibits migration, demonstrating that precise regulation of CaMKIIβ expression is required for correct neuronal migration. More precisely, CaMKIIβ controls the multipolar-bipolar transition in the intermediate zone and locomotion in the cortical plate through its actin-binding and -bundling activities. In addition, our data indicate that a fine-tuned balance between CaMKIIβ and cofilin activities is necessary to ensure proper migration of cortical neurons. Thus, our findings define a novel isoform-specific function for CaMKIIβ, demonstrating that CaMKIIβ has a major biological function in the developing brain.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29712998      PMCID: PMC6129389          DOI: 10.1038/s41380-018-0046-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  64 in total

1.  βCaMKII in lateral habenula mediates core symptoms of depression.

Authors:  Kun Li; Tao Zhou; Lujian Liao; Zhongfei Yang; Catherine Wong; Fritz Henn; Roberto Malinow; John R Yates; Hailan Hu
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

Review 2.  The Ca2+ and Rho GTPase signaling pathways underlying activity-dependent actin remodeling at dendritic spines.

Authors:  Takeo Saneyoshi; Yasunori Hayashi
Journal:  Cytoskeleton (Hoboken)       Date:  2012-05-22

3.  γCaMKII shuttles Ca²⁺/CaM to the nucleus to trigger CREB phosphorylation and gene expression.

Authors:  Huan Ma; Rachel D Groth; Samuel M Cohen; John F Emery; Boxing Li; Esthelle Hoedt; Guoan Zhang; Thomas A Neubert; Richard W Tsien
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

4.  Phosphomimetic S3D cofilin binds but only weakly severs actin filaments.

Authors:  W Austin Elam; Wenxiang Cao; Hyeran Kang; Andrew Huehn; Glen M Hocky; Ewa Prochniewicz; Anthony C Schramm; Karina Negrón; Jean Garcia; Teresa T Bonello; Peter W Gunning; David D Thomas; Gregory A Voth; Charles V Sindelar; Enrique M De La Cruz
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

5.  CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons.

Authors:  Franck Oury; Vijay K Yadav; Ying Wang; Bin Zhou; X Sherry Liu; X Edward Guo; Laurence H Tecott; Günther Schutz; Anthony R Means; Gerard Karsenty
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

6.  Calcium-calmodulin-dependent protein kinase II isoforms differentially impact the dynamics and structure of the actin cytoskeleton.

Authors:  Laurel Hoffman; Madeline M Farley; M Neal Waxham
Journal:  Biochemistry       Date:  2013-02-04       Impact factor: 3.162

7.  SDCCAG8 regulates pericentriolar material recruitment and neuronal migration in the developing cortex.

Authors:  Ryan Insolera; Wei Shao; Rannar Airik; Friedhelm Hildebrandt; Song-Hai Shi
Journal:  Neuron       Date:  2014-07-31       Impact factor: 17.173

8.  Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII.

Authors:  Charles C Fink; Karl-Ulrich Bayer; Jason W Myers; James E Ferrell; Howard Schulman; Tobias Meyer
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

9.  Transcriptomic analysis of autistic brain reveals convergent molecular pathology.

Authors:  Irina Voineagu; Xinchen Wang; Patrick Johnston; Jennifer K Lowe; Yuan Tian; Steve Horvath; Jonathan Mill; Rita M Cantor; Benjamin J Blencowe; Daniel H Geschwind
Journal:  Nature       Date:  2011-05-25       Impact factor: 49.962

10.  A CaMKIIβ signaling pathway at the centrosome regulates dendrite patterning in the brain.

Authors:  Sidharth V Puram; Albert H Kim; Yoshiho Ikeuchi; Joshua T Wilson-Grady; Andreas Merdes; Steven P Gygi; Azad Bonni
Journal:  Nat Neurosci       Date:  2011-07-03       Impact factor: 24.884

View more
  3 in total

Review 1.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 2.  CaMKIIβ in Neuronal Development and Plasticity: An Emerging Candidate in Brain Diseases.

Authors:  Olivier Nicole; Emilie Pacary
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

3.  Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons.

Authors:  Karen Runge; Rémi Mathieu; Stéphane Bugeon; Carlos Cardoso; Harold Cremer; Sahra Lafi; Corinne Beurrier; Surajit Sahu; Fabienne Schaller; Arthur Loubat; Leonard Herault; Stéphane Gaillard; Emilie Pallesi-Pocachard; Aurélie Montheil; Andreas Bosio; Jill A Rosenfeld; Eva Hudson; Kristin Lindstrom; Saadet Mercimek-Andrews; Lauren Jeffries; Arie van Haeringen; Olivier Vanakker; Audrey Van Hecke; Dina Amrom; Sebastien Küry; Chana Ratner; Reena Jethva; Candace Gamble; Bernard Jacq; Laurent Fasano; Gabriel Santpere; Belen Lorente-Galdos; Nenad Sestan; Antoinette Gelot; Sylvie Giacuzz; Sandra Goebbels; Alfonso Represa; Antoine de Chevigny
Journal:  Mol Psychiatry       Date:  2021-06-29       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.